News

A new treatment against chronic hepatitis C

- Een nieuwe behandeling tegen chronische hepatitis C met het geneesmiddel Vosevi wordt vanaf 1 juli 2018 vergoed vanuit het basispakket.

Internet consultation on Microplastics & Health call offers valuable insight

- In preparation of the Microplastic & Health call for research proposals the concept call text went on-line for feedback. It was an open invitation for any stakeholders to participate. The aim of the consultation was to improve the quality of the call in terms of relevance to knowledge gaps and a way in which to adjust the call to the current state of scientific knowledge.

Biotech at its best at BIO 2018 in Boston

- With a well-visited Health~Holland Pavilion and a strong delegation of 130 Dutch biotech entrepreneurs, this year’s BIO International Convention in Boston, Massachusetts, at the epicentre of biotech proved to be a fruitful edition for the Dutch too.

Top Sector LSH and Health Funds support the project MyOwnResearch with 2,6 million

- Een samenwerkingsproject waarin patiënten, onderzoekers en bedrijven helpen meerwaarde te halen uit het zelfonderzoek van patiënten naar de beste behandeling van hun chronische ziekte

Six researchers awarded with highest award in Dutch science

- Vandaag maakte NWO-voorzitter Stan Gielen bekend dat prof. dr. Anna Akhmanova, prof. dr. Marileen Dogterom, prof. dr. Carsten de Dreu en prof. dr. John van der Oost de NWO-Spinozapremie ontvangen, en prof. dr. Beatrice de Graaf en prof. dr. Marion Koopmans de NWO-Stevinpremie. De Spinoza- en de Stevinpremies zijn de hoogste onderscheidingen in de Nederlandse wetenschap. De laureaten krijgen elk 2,5 miljoen euro, te besteden aan wetenschappelijk onderzoek en activiteiten met betrekking tot kennisbenutting.

Open call for applications - Female Junior Investigator Programme

- Oncode Institute has opened a call for applications for our Female Junior Investigator Programme (FJIP). Up to eight young female scientists will each be awarded € 150k,- per year during the first phase of Oncode, ending in 2022. The programme aims to support talented female junior investigators who have established their own line of research. Female scientists from all Dutch universities and research institutes can apply for funding.

Chemotherapy, at home

- Kankercentra en een verzekeraar maken werk van de thuisbehandeling van kanker - tot voor kort ondenkbaar. Dit meldt de Volkskrant.

AMC and VUmc go forward together as Amsterdam UMC

- Het Academisch Medisch Centrum (AMC) en VU medisch centrum (VUmc) zijn vandaag bestuurlijk gefuseerd.

InSciTe project that targets new way to take eye medicines enters clinical studies

- One of the projects of InSciTe has been granted permission by the ‘Dutch Health and Youth Care Inspection’ (Inspectie Gezondheidszorg en Jeugd) to enter the clinical test phase. The Ocular Coil Drug Delivery Comfort Trial (OCDC) project developed an innovative way to apply medication to the eye. OCDC is the first public/private collaborative InSciTe project to reach this crucial phase within 3 years. This is an important achievement for the project partners and InSciTe.

EMA’s digital transformation: new Orphan Drug Designation application system

- As of June 15th, the European Medicines Agency (EMA) starts the voluntary use of its Scientific and Regulatory Evaluation Procedure Support (S-REPS) for Orphan Drug Designation applications. From September 15th onwards, S-REPS will become mandatory for these applications, replacing the current PDF and Word form-based submission.